D-1437-2019 Class II Terminated

Recalled by Geritrex, LLC — Middletown, NY

FDA drug recall D-1437-2019 was initiated by Geritrex, LLC on May 6, 2019 and is designated Class II. Reason for recall: Failed Impurities/Degradation Specifications: Atypical odor and unpleasant taste was reported The recall status is terminated (terminated Feb 21, 2024). Affected quantity: 24312 units.

Recall details

Product Type
Drugs
Report Date
Jun 19, 2019
Initiation Date
May 6, 2019
Termination Date
Feb 21, 2024
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
24312 units

Product description

Senna (sennosides 8.8 mg) Syrup 8 fl oz. (236 mL) bottles, Distributed by Geritrex, LLC 40 Commercial Avenue Middletown, NY 10941, NDC 54162-007-08

Reason for recall

Failed Impurities/Degradation Specifications: Atypical odor and unpleasant taste was reported

Distribution pattern

Nationwide within the United States

Code information

Lot #: 1806031, 1806014, Exp. 08/2019

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-1437-2019
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-1437-2019. Report a data issue: hello@regdatalab.com.